BSE - SMEListed
Earum Pharmaceuticals Limited
Company websiteEarum Pharmaceuticals Limited is launching an IPO sized at ₹18,48,000 crore. The raise comprises a fresh issue of ₹0 crore and an OFS of ₹0 crore, together representing roughly 3000 shares.
Subscription is open from 21-06-2019 to 26-06-2019. The allotment is expected on 01-07-2019, and listing is targeted for 04-07-2019. Note: fresh issue proceeds typically go to the company while OFS proceeds go to selling shareholders.
Start Date21-06-2019
End Date26-06-2019
Listing Date04-07-2019
Allotment Date01-07-2019
Current Price₹36
GMP₹0 (0.00%)
Lot Size3000 Shares
Subscription0 Times
Face Value₹10 per share
Listing atBSE
Issue Price₹36 - ₹36
Pre Issue₹43,19,910
Post Issue₹61,67,910
Issue Size₹18,48,000
(aggregating up to 7.00 Cr)
(aggregating up to 7.00 Cr)
Fresh Issue
(aggregating up to 0.00 Cr)
(aggregating up to 0.00 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Earum Pharmaceuticals Limited is currently around ₹0 (0.00%). This indicates an estimated listing price of approximately ₹36 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
17 Apr 2025, 10:13 | ₹36 | ₹0 | ₹36 (0.00%) |
Financials overview in Lakhs
Here is a quick look at the recent financial performance of Earum Pharmaceuticals Limited . The numbers below ( in Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
The IPO reservation for Earum Pharmaceuticals Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Market Maker | 5.19% | 96,000 |
HNI | 47.40% | 8,76,000 |
RETAIL | 47.40% | 8,76,000 |
TOTAL | 100.00% | 18,48,000 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 3,000 | ₹1,08,000 | |
HNI | 2 | 6,000 | ₹2,16,000 |
Below you can find the official contact details of Earum Pharmaceuticals Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@earumpharma.com
Phone: +91-79-48402525
Website: http://www.earumpharma.com/
Address: G1, Ground Floor, V R Complex, Near Sanathal Cross Road, SP Ring Road, Sanathal, Ahmedabad, Gujarat-382210,